UnicoCell Biomed Balance Sheet Health
Financial Health criteria checks 6/6
UnicoCell Biomed has a total shareholder equity of NT$705.7M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$796.5M and NT$90.8M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$603.53m |
| Equity | NT$705.70m |
| Total liabilities | NT$90.79m |
| Total assets | NT$796.49m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 6794's short term assets (NT$635.7M) exceed its short term liabilities (NT$23.1M).
Long Term Liabilities: 6794's short term assets (NT$635.7M) exceed its long term liabilities (NT$67.7M).
Debt to Equity History and Analysis
Debt Level: 6794 is debt free.
Reducing Debt: 6794 has no debt compared to 5 years ago when its debt to equity ratio was 11.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6794 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6794 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 5.5% each year